• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚焦JAK-STAT信号通路中的氨基酸改变突变:从疾病特异性突变到通用突变数据库

Spotlight on amino acid changing mutations in the JAK-STAT pathway: from disease-specific mutation to general mutation databases.

作者信息

Hoffmann Markus, Hennighausen Lothar

机构信息

Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 20892, USA.

出版信息

Sci Rep. 2025 Feb 20;15(1):6202. doi: 10.1038/s41598-025-90788-5.

DOI:10.1038/s41598-025-90788-5
PMID:39979591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11842829/
Abstract

The JAK-STAT pathway is central to cytokine signaling and controls normal physiology and disease. Aberrant activation via mutations that change amino acids in proteins of the pathway can result in diseases. While disease-centric databases like COSMIC catalog mutations in cancer, their prevalence in healthy populations remains underexplored. We systematically studied such mutations in the JAK-STAT genes by comparing COSMIC and the population-focused All of Us database. Our analysis revealed frequent mutations in all JAK and STAT domains, particularly among white females. We further identified three categories: Mutations uniquely found in All of Us that were associated with cancer in the literature but could not be found in COSMIC, underscoring COSMIC's limitations. Mutations unique to COSMIC underline their potential as drivers of cancer due to their absence in the general population. Mutations present in both databases, e.g., JAK2 - widely recognized as a cancer driver in hematopoietic cells, but without disease associations in All of Us, raising the possibility that combinatorial SNPs might be responsible for disease development. These findings illustrate the complementarity of both databases for understanding mutation impacts and underscore the need for multi-mutation analyses to uncover genetic factors underlying complex diseases and advance personalized medicine.

摘要

JAK-STAT信号通路是细胞因子信号传导的核心,控制着正常生理功能和疾病发生。该信号通路中蛋白质氨基酸发生突变导致的异常激活会引发疾病。尽管像COSMIC这样以疾病为中心的数据库收录了癌症中的突变情况,但这些突变在健康人群中的发生率仍未得到充分研究。我们通过比较COSMIC和以人群为重点的“我们所有人”数据库,系统地研究了JAK-STAT基因中的此类突变。我们的分析揭示了所有JAK和STAT结构域中都存在频繁的突变,尤其是在白人女性中。我们进一步确定了三类突变:在“我们所有人”数据库中独特发现的、在文献中与癌症相关但在COSMIC中未发现的突变,这突出了COSMIC的局限性;COSMIC中独有的突变,由于其在普通人群中不存在,突显了它们作为癌症驱动因素的潜力;两个数据库中都存在的突变,例如JAK2——在造血细胞中被广泛认为是癌症驱动因素,但在“我们所有人”数据库中没有疾病关联,这增加了组合单核苷酸多态性可能导致疾病发展的可能性。这些发现说明了两个数据库在理解突变影响方面的互补性,并强调了进行多突变分析以揭示复杂疾病潜在遗传因素和推进个性化医疗的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e273/11842829/df53ae084517/41598_2025_90788_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e273/11842829/094f2dcbaf8b/41598_2025_90788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e273/11842829/df53ae084517/41598_2025_90788_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e273/11842829/094f2dcbaf8b/41598_2025_90788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e273/11842829/df53ae084517/41598_2025_90788_Fig2_HTML.jpg

相似文献

1
Spotlight on amino acid changing mutations in the JAK-STAT pathway: from disease-specific mutation to general mutation databases.聚焦JAK-STAT信号通路中的氨基酸改变突变:从疾病特异性突变到通用突变数据库
Sci Rep. 2025 Feb 20;15(1):6202. doi: 10.1038/s41598-025-90788-5.
2
Mining for JAK-STAT mutations in cancer.挖掘癌症中的JAK-STAT突变
Trends Biochem Sci. 2008 Mar;33(3):122-31. doi: 10.1016/j.tibs.2007.12.002.
3
JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.JAK/STAT/SOCS 信号通路与结直肠癌。
Mol Carcinog. 2013 Feb;52(2):155-66. doi: 10.1002/mc.21841. Epub 2011 Nov 28.
4
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis.综合基因组分析阐明了 JAK-STAT 通路激活在骨髓增殖性肿瘤发病机制中的核心作用。
Blood. 2014 May 29;123(22):e123-33. doi: 10.1182/blood-2014-02-554634. Epub 2014 Apr 16.
5
JAK/STAT signaling in hematological malignancies.JAK/STAT 信号通路在血液系统恶性肿瘤中的作用。
Oncogene. 2013 May 23;32(21):2601-13. doi: 10.1038/onc.2012.347. Epub 2012 Aug 6.
6
The JAK/STAT signaling pathway: from bench to clinic.JAK/STAT 信号通路:从基础到临床。
Signal Transduct Target Ther. 2021 Nov 26;6(1):402. doi: 10.1038/s41392-021-00791-1.
7
Mutations in the JAK/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T-cell lymphoma.JAK/STAT信号通路基因的突变以及该通路的激活,这是结内外周T细胞淋巴瘤中的一项相关发现。
Br J Haematol. 2018 Nov;183(3):497-501. doi: 10.1111/bjh.14984. Epub 2017 Oct 26.
8
The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling.T 细胞白血病相关核糖体 RPL10 R98S 突变增强了 JAK-STAT 信号通路。
Leukemia. 2018 Mar;32(3):809-819. doi: 10.1038/leu.2017.225. Epub 2017 Jul 24.
9
JAK2 V617F-dependent upregulation of PU.1 expression in the peripheral blood of myeloproliferative neoplasm patients.JAK2 V617F 依赖性上调骨髓增殖性肿瘤患者外周血中 PU.1 的表达。
PLoS One. 2011;6(7):e22148. doi: 10.1371/journal.pone.0022148. Epub 2011 Jul 18.
10
Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer.Janus 激酶 - 信号转导和转录激活因子抑制剂在癌症治疗和管理中的应用。
J Environ Pathol Toxicol Oncol. 2023;42(4):15-29. doi: 10.1615/JEnvironPatholToxicolOncol.2023045403.

本文引用的文献

1
New advances in the role of JAK2 V617F mutation in myeloproliferative neoplasms.JAK2 V617F 突变在骨髓增殖性肿瘤中的作用的新进展。
Cancer. 2024 Dec 15;130(24):4229-4240. doi: 10.1002/cncr.35559. Epub 2024 Sep 14.
2
Challenges in Diagnosing Polycythemia Vera in Primary Care: A 55-Year-Old Malaysian Woman with Atypical Presentation.初级保健中真性红细胞增多症诊断的挑战:一位有非典型表现的 55 岁马来西亚女性。
Am J Case Rep. 2024 Sep 12;25:e944202. doi: 10.12659/AJCR.944202.
3
The survivin/XIAP suppressant YM155 impairs clonal growth and induces apoptosis in JAK2 cells.
存活素/ X连锁凋亡抑制蛋白抑制剂YM155损害JAK2细胞的克隆生长并诱导其凋亡。
Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S217-S227. doi: 10.1016/j.htct.2024.05.012. Epub 2024 Sep 7.
4
Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasms.JAK2V617F 相关性骨髓增殖性肿瘤中的纤维蛋白溶解受损。
J Thromb Haemost. 2024 Nov;22(11):3199-3208. doi: 10.1016/j.jtha.2024.07.031. Epub 2024 Sep 12.
5
JAK2 impairs lymphoid differentiation in myeloproliferative neoplasms.JAK2损害骨髓增殖性肿瘤中的淋巴细胞分化。
Leukemia. 2024 Nov;38(11):2487-2491. doi: 10.1038/s41375-024-02388-3. Epub 2024 Sep 7.
6
Network medicine-based epistasis detection in complex diseases: ready for quantum computing.基于网络医学的复杂疾病上位性检测:准备迎接量子计算。
Nucleic Acids Res. 2024 Sep 23;52(17):10144-10160. doi: 10.1093/nar/gkae697.
7
Incidence and impact of non-canonical JAK2 p.(Val617Phe) mutations in myeloproliferative neoplasm molecular diagnostics.非典型JAK2 p.(Val617Phe)突变在骨髓增殖性肿瘤分子诊断中的发生率及影响
J Clin Pathol. 2025 Jan 17;78(2):139-140. doi: 10.1136/jcp-2023-209276.
8
Multi-trait GWAS for diverse ancestries: mapping the knowledge gap.多特征全基因组关联研究在不同祖先群体中的应用:填补知识空白。
BMC Genomics. 2024 Apr 17;25(1):375. doi: 10.1186/s12864-024-10293-3.
9
Clinical laboratory characteristics and gene mutation spectrum of Ph-negative MPN patients with atypical variants of JAK2, MPL, or CALR.具有JAK2、MPL或CALR非典型变异的Ph阴性骨髓增殖性肿瘤患者的临床实验室特征及基因突变谱
Cancer Med. 2024 Apr;13(7):e7123. doi: 10.1002/cam4.7123.
10
Decoding Non-coding Variants: Recent Approaches to Studying Their Role in Gene Regulation and Human Diseases.解码非编码变异:研究其在基因调控和人类疾病中作用的最新方法。
Front Biosci (Schol Ed). 2024 Mar 1;16(1):4. doi: 10.31083/j.fbs1601004.